Human Metabolome Technologies Dividend
Dividend criteria checks 3/6
Human Metabolome Technologies is a dividend paying company with a current yield of 2.33% that is well covered by earnings. Next payment date is on 9th September, 2024 with an ex-dividend date of 27th June, 2024.
Key information
2.3%
Dividend yield
21%
Payout ratio
| Industry average yield | 2.4% |
| Next dividend pay date | 09 Sep 24 |
| Ex dividend date | 27 Jun 24 |
| Dividend per share | n/a |
| Earnings per share | JP¥47.67 |
| Dividend yield forecast in 3Y | n/a |
Upcoming Dividend Payment
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Too early to tell whether 6090's dividend payments have been stable as they only just started paying a dividend.
Growing Dividend: Too early to tell if 6090's dividend payments are increasing as they only just started paying a dividend.
Dividend Yield vs Market
| Human Metabolome Technologies Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (6090) | 2.3% |
| Market Bottom 25% (JP) | 1.6% |
| Market Top 25% (JP) | 3.2% |
| Industry Average (Life Sciences) | 2.4% |
| Analyst forecast in 3 Years (6090) | n/a |
Notable Dividend: 6090's dividend (2.33%) is higher than the bottom 25% of dividend payers in the JP market (1.6%).
High Dividend: 6090's dividend (2.33%) is low compared to the top 25% of dividend payers in the JP market (3.22%).
Earnings Payout to Shareholders
Earnings Coverage: With its low payout ratio (21%), 6090's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonable cash payout ratio (66.2%), 6090's dividend payments are covered by cash flows.